For early-stage lung cancer, the treatment of choice is surgery. In patients who are not surgical candidates or are unwilling to undergo surgery, radiotherapy is the principal treatment option. Here, we review stereotactic body radiotherapy, a technique that has produced quite promising results in such patients and should be the treatment of choice, if available. We also present the major indications, technical aspects, results, and special situations related to the technique.

The impact of FM measured by the FIQ is directly correlated with the severity of depression and the presence of workers' compensation interests.

No abstract

No abstract

No abstract

No abstract

No abstract

No abstract